Aliaxin® EV

ALIAXIN® EV Product Description

ALIAXIN® EV Essential Volume is a reabsorbable, cross-linked hyaluronic acid-based filler designed to address deep facial cutaneous sagging and restore volume. It is produced by bacterial fermentation and is of non-animal origin. The product is sterile, apyrogenic, and presented as a physiological gel.

Key Details:

Composition: 25 mg/g of cross-linked hyaluronic acid, phosphate-buffered saline, and water for injectable solutions.
Packaging: Includes two 1 mL pre-filled sterile syringes, 27G needles, and adhesive labels for patient records.
ALIAXIN® EV Key Features and Benefits

This filler is designed for deep wrinkle correction and volume restoration, offering benefits such as:

Hydration and elasticity improvement.
Long-lasting effects due to its biodegradability.
Restored volume in facial areas, achieving a natural look.

Advantages:

Correction of deep wrinkles.
Volume enhancement in cheeks, chin, and cheekbones.
Treatment of nasolabial folds and post-acne scars.
ALIAXIN® EV Composition

Active Ingredients:

Cross-linked hyaluronic acid: 25 mg/g for volume restoration.
Physiological pH phosphate-buffered saline: ensures biocompatibility.
ALIAXIN® EV Intended Purpose / Indications

ALIAXIN® EV is suitable for:

Deep wrinkle correction and cutaneous depressions.
Volume restoration in areas like cheeks, chin, and cheekbones.
Treatment of nasolabial folds and post-traumatic scars.
ALIAXIN® EV Injection and Treatment Areas

Recommended areas and injection guidelines:

Subcutaneous layer: for soft tissue augmentation.
Treatment sites: cheeks, chin, cheekbones, and nasolabial folds.
Ensure symmetrical application for natural outcomes.
ALIAXIN® EV Reconstitution and Preparation Guidelines

Preparation involves:

Clean the area with an antiseptic solution.
Use the 27G needle provided in the package.
Extract air from the syringe before injection.
Maintain sterile conditions throughout the preparation.
ALIAXIN® EV Administration and Dosage

Administration is determined by a trained practitioner:

Injection depth: superficial subcutaneous layer.
Dosage varies based on the desired correction.
Regular maintenance every 8-12 months for sustained results.
Avoid over-correction to ensure natural outcomes.
ALIAXIN® EV Storage Instructions
Store at 2°C to 28°C, protected from light.
Do not freeze.
Ensure sterility and avoid using damaged packages.
ALIAXIN® EV Contraindications

Avoid use in:

Patients under 18 or during pregnancy and breastfeeding.
Areas with active infections, inflammation, or autoimmune diseases.
Patients with allergies to components or a history of anaphylactic shock.
ALIAXIN® EV Precautions and Warnings

Practitioners should:

Avoid injecting into blood vessels to prevent adverse reactions.
Refrain from treating areas with existing permanent implants.
Advise patients to avoid vitamin E, aspirin, and anticoagulants before treatment to minimize bruising.
ALIAXIN® EV Post-Treatment Care

Recommendations for patients:

Avoid makeup for 12 hours post-injection.
Protect treated areas from extreme temperatures (hot or cold) and UV exposure for two weeks.
Avoid applying pressure to the treated areas.
ALIAXIN® EV Side Effects and Adverse Reactions

Common side effects include:

Redness, swelling, and tenderness at the injection site.
Bruising, hematoma, and mild pain.
Rare adverse effects: granuloma formation, cutaneous necrosis, or hypersensitivity reactions.
ALIAXIN® EV Patient Eligibility

Suitable for individuals:

Aged 18 and above.
Without active skin conditions or a history of severe allergic reactions.